Today's signals · No active technical signal.
Signal details →Prelude Therapeutics last closed at $3.81 (+1.06%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -6.1×. Its overall grade ranks 175 of 741 stocks in Healthcare.
About this company
Prelude Therapeutics last closed at $3.81 (+1.06%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 175/741
Valuation grade B+
Related stocks
- Bristol-Myers SquibbCustomer
Prelude의 기술이전/협력 가능성이 있는 대형 제약사로, 임상·상업화 파트너 측면에서 중요
- AbbVieCompetitor
혈액암·면역질환 등 표적항암제/저분자 신약 개발에서 경쟁하는 대형 제약사
- NovartisCompetitor
종양학 및 표적치료제 파이프라인에서 경쟁하는 글로벌 제약사
About Prelude Therapeutics
- What technical signals does Prelude Therapeutics (PRLD) have?
- Prelude Therapeutics current technical signals: no active technical signal.
- Is Prelude Therapeutics a cup-and-handle pattern?
- No. Prelude Therapeutics has no valid Cup signal right now.
- What published figures are available for Prelude Therapeutics?
- Market cap: $190.56M. Trailing 12 months PER: -6.1×. Latest quarter PBR: 2.77×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Prelude Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.